Please login to the form below

Not currently logged in
Email:
Password:

Thomas Wellner appointed CEO of CML Healthcare

Former president and general manager of Lilly Germany joins Canada-based provider of laboratory testing services

Former president and general manager of Lilly Germany Thomas Wellner has been appointed CEO of CML Healthcare.

Wellner takes over from company chair Patrice Merrin, who had been interim CEO of the Canada-based provider of laboratory testing services since May, 2011.

"We are very pleased to welcome Tom Wellner to CML,” said Merrin. “During the course of his career, Tom has had exposure to numerous healthcare and payor systems as well as to the critical interface of diagnostics, physicians, patients and treatment regimens.”

Prior to his new appointment, Wellner was president and CEO of Canadian biopharma Therapure Biopharma, from 2008 to 2011.

Before his time at Theapure he spent a total of 20 years at Eli Lilly & Company holding senior roles in China, the US, the UK and Latin America.

These included executive director marketing and sales, European Operations at Eli Lilly and Company and director marketing at Eli Lilly Canada, as well as his position in Germany.

9th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics